Stress and corticosteroid modulation of seizures and synaptic inhibition in the hippocampus

Experimental Neurology

Volumn 234, Issue 1, 2012, Pages 200-207

  Maggio, Nicola ^a,b   Segal, Menahem ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Corticosteroids; Hippocampus; Kainic acid; Seizures; Stress

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID RECEPTOR; KAINIC ACID; MINERALOCORTICOID RECEPTOR; PROTEIN KINASE;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PYRAMIDAL NERVE CELL; RAT; SEIZURE; STRESS; SYNAPTIC INHIBITION; TISSUE SLICE;

ADRENAL CORTEX HORMONES; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; BIOPHYSICS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIALS; KAINIC ACID; MALE; MIFEPRISTONE; NEURAL INHIBITION; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; REACTION TIME; SEIZURES; SPIRONOLACTONE; STRESS, PSYCHOLOGICAL; SYNAPSES; TIME FACTORS;

EID: 84857500038     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.12.035     Document Type: Article

References (40)

1. Arida R.M., Scorza F.A., Terra V.C., Scorza C.A., de Almeida A.C., Cavalheiro E.A. Physical exercise in epilepsy: what kind of stressor is it?. Epilepsy Behav. 2009, 16:381-387.
2. Belelli D., Harrison N.L., Maguire J., Macdonald R.L., Walker M.C., Cope D.W. Extrasynaptic GABAA receptors: form, pharmacology, and function. J. Neurosci. 2009, 29:12757-12763.
3. Benkovic S.A., O'Callaghan J.P., Miller D.B. Protracted exposure to supraphysiological levels of corticosterone does not cause neuronal loss or damage and protects against kainic acid-induced neurotoxicity in the hippocampus of C57BL/6J mice. Neurotoxicology 2009, 30:965-976.
4. Chou W.H., Wang D., McMahon T., Qi Z.H., Song M., Zhang C., Shokat K.M., Messing R.O. GABAA receptor trafficking is regulated by protein kinase C(epsilon) and the N-ethylmaleimide-sensitive factor. J. Neurosci. 2010, 30:13955-13965.
5. Dudek F.E., Clark J., Willimas P.A., Grabenstatter H.L. Kainate-induced status epilepticus: a chronic model of acquired epilepsy. Models of seizures and epilepsy 2006, Elsevier. A. Pitkanen, P.A. Schwartzkroin, S.L. Mose' (Eds.).
6. Finn D.A., Roberts A.J., Long S., Tanchuck M., Phillips T.J. Neurosteroid consumption has anxiolytic effects in mice. Pharmacol. Biochem. Behav. 2003, 76:451-462.
7. Frucht M.M., Quigg M., Schwaner C., Fountain N.B. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000, 41(12):1534-1539.
8. Garcia R. Stress, metaplasticity, and antidepressants. Curr. Mol. Med. 2002, 2(7):629-638.
9. Goodkin H.P., Sun C., Yeh J.L., Mangan P.S., Kapur J. GABA(A) receptor internalization during seizures. Epilepsia 2007, 48(Suppl 5):109-113.
10. Goodkin H.P., Joshi S., Mtchedlishvili Z., Brar J., Kapur J. Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J. Neurosci. 2008, 28:2527-2538.
11. Groc L., Choquet D., Chaouloff F. The stress hormone corticosterone conditions AMPAR surface trafficking and synaptic potentiation. Nat. Neurosci. 2008, 11(8):868-870.
12. Haut S.R., Vouyiouklis M., Shinnar S. Stress and epilepsy: a patient perception survey. Epilepsy Behav. 2003, 5:511-514.
13. Jacobson-Pick S., Richter-Levin G. Differential impact of juvenile stress and corticosterone in juvenility and in adulthood in male and female rats. Behav. Brain Res. 2010, 214(2):268-276.
14. Joels M. Functional actions of corticosteroids in the hippocampus. Eur. J. Pharmacol. 2008, 583:312-321.
15. Joels M. Stress, the hippocampus, and epilepsy. Epilepsia 2009, 50(4):586-597.
16. Karst H., Joels M. Corticosterone slowly enhances miniature excitatory postsynaptic current amplitude in mice CA1 hippocampal cells. J. Neurophysiol. 2005, 94(5):3479-3486.
17. Kim J.J., Song E.Y., Kosten T.A. Stress effects in the hippocampus: synaptic plasticity and memory. Stress 2006, 9(1):1-11.
18. Kim H., Lee J.M., Park J.S., Jo S.A., Kim Y.O., Kim C.W., et al. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem. Biophys. Res. Commun. 2008, 372(1):243-248. (18).
19. Krugers H.J., Alfarez D.N., Karst H., Parashkouhi K., van Gemert N., Joels M. Corticosterone shifts different forms of synaptic potentiation in opposite directions. Hippocampus 2005, 15:697-703.
20. Lephart E.D., Ojeda S.R. Hypothalamic aromatase activity in male and female rats during juvenile peripubertal development. Neuroendocrinology 1990, 51(4):385-393.
21. Maggio N., Segal M. Striking variations in corticosteroid modulation of long-term potentiation along the septotemporal axis of the hippocampus. J. Neurosci. 2007, 27:5757-5765.
22. Maggio N., Segal M. Differential corticosteroid modulation of inhibitory synaptic currents in the dorsal and ventral hippocampus. J. Neurosci. 2009, 29:2857-2866.
23. Maggio N., Segal M. Differential modulation of long-term depression by acute stress in the rat dorsal and ventral hippocampus. J. Neurosci. 2009, 29:8633-8638.
24. Maggio N., Segal M. Persistent changes in ability to express long term potentiation/depression in the rat hippocampus after juvenile/adult stress. Biol. Psychiatry 2011, 69(8):748-53. (15).
25. Nakken K.O., Solaas M.H., Kjeldsen M.J., Friis M.L., Pellock J.M., Corey L.A. Which seizure-precipitating factors do patients with epilepsy most frequently report?. Epilepsy Behav. 2005, 6(1):85-89.
26. Ojeda S.R., Advis J.P., Andrews W.W. Neuroendocrine control of the onset of puberty in the rat. Fed. Proc. 1980, 39(7):2365-2367.
27. Orchinik M., Carroll S.S., Li Y.H., McEwen B.S., Weiland N.G. Heterogeneity of hippocampal GABA(A) receptors: regulation by corticosterone. J. Neurosci. 2001, 21(1):330-339.
28. Pericic D., Svob D., Jazvinscak M., Mirkovic K. Anticonvulsive effect of swim stress in mice. Pharmacol. Biochem. Behav. 2000, 66(4):879-886.
29. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
30. Scaccianoce S., Alema G.S., Cigliana G., Nicolai R., Buttarelli F.R., Angelucci L. Neurotoxicity of kainate to the hippocampus is not accrued by aging, stress and exogenous corticosterone in Wistar Kyoto and spontaneously hypertensive rats. Stress 1997, 1(4):201-212.
31. Segal M., Richter-Levin G., Maggio N. Stress-induced dynamic routing of hippocampal connectivity: a hypothesis. Hippocampus 2010, 20:1332-1338.
32. Shlosberg D., Benifla M., Kaufer D., Friedman A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 2010, 6(7):393-403.
33. Soffietti R., Ruda R., Mutani R. Management of brain metastases. J. Neurol. 2002, 249(10):1357-1369. (Oct.).
34. Sperk G. Changes in GABAA receptors in status epilepticus. Epilepsia 2007, 48(Supp 8):11-13.
35. Stein-Behrens B., Mattson M.P., Chang I., Yeh M., Sapolsky R. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 1994, 14(9):5373-5380.
36. Talmi M., Carlier E., Bengelloun W., Soumireu-Mourat B. Synergistic action of corticosterone on kainic acid-induced electrophysiological alterations in the hippocampus. Brain Res. 1995, 704:97-102.
37. Terunuma M., Xu J., Vithlani M., Sieghart W., Kittler J., Pangalos M., et al. Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus. J. Neurosci. 2008, 28(2):376-384.
38. Wang C.C., Wang S.J. Modulation of presynaptic glucocorticoid receptors on glutamate release from rat hippocampal nerve terminals. Synapse 2009, 63(9):745-751.
39. Wen P.Y., Marks P.W. Medical management of patients with brain tumors. Curr. Opin. Oncol. 2002, 14(3):299-307.
40. Zhou Q.X., Mao R.R., Duan T.T., Tan J.W., Tian M., Cao J., et al. Stress within the postseizure time window inhibits seizure recurrence. Epilepsy Behav. 2010, 18:201-206.